Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer. [electronic resource] by
- Viswanadhapalli, Suryavathi
- Luo, Yiliao
- Sareddy, Gangadhara R
- Santhamma, Bindu
- Zhou, Mei
- Li, Mengxing
- Ma, Shihong
- Sonavane, Rajni
- Pratap, Uday P
- Altwegg, Kristin A
- Li, Xiaonan
- Chang, Annabel
- Chávez-Riveros, Alejandra
- Dileep, Kalarickal V
- Zhang, Kam Y J
- Pan, Xinlei
- Murali, Ramachandran
- Bajda, Marek
- Raj, Ganesh V
- Brenner, Andrew J
- Manthati, Vijaya
- Rao, Manjeet K
- Tekmal, Rajeshwar R
- Nair, Hareesh B
- Nickisch, Klaus J
- Vadlamudi, Ratna K
Producer: 20190826
In:
Molecular cancer therapeutics vol. 18
Availability: No items available.
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling. [electronic resource] by
- Yue, Xuetian
- Wu, Fangnan
- Wang, Jianming
- Kim, Kaitlin
- Santhamma, Bindu
- Dileep, Kalarickal V
- Zhang, Kam Y J
- Viswanadhapalli, Suryavathi
- Vadlamudi, Ratna K
- Ahmed, Gulzar
- Feng, Zhaohui
- Nickisch, Klaus
- Hu, Wenwei
Producer: 20210813
In:
Journal of molecular cell biology vol. 12
Availability: No items available.
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|